| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ... Nature genetics 45 (12), 1452-1458, 2013 | 4587 | 2013 |
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ... Nature genetics 41 (10), 1088-1093, 2009 | 3408 | 2009 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2470 | 2019 |
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ... Nature genetics 43 (5), 429-435, 2011 | 2252 | 2011 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 959 | 2017 |
| Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease L Jones, PA Holmans, ML Hamshere, D Harold, V Moskvina, D Ivanov, ... PloS one 5 (11), e13950, 2010 | 461 | 2010 |
| GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer’s disease C Cruchaga, JSK Kauwe, O Harari, SC Jin, Y Cai, CM Karch, BA Benitez, ... Neuron 78 (2), 256-268, 2013 | 414 | 2013 |
| European Alzheimer’s Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer’s Disease; Alzheimer’s Disease Genetic Consortium; Cohorts for Heart and Aging … JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ... Nat Genet 45 (12), 1452-1458, 2013 | 297 | 2013 |
| Convergent genetic and expression data implicate immunity in Alzheimer's disease International Genomics of Alzheimer's Disease Consortium (IGAP), ... Alzheimer's & Dementia 11 (6), 658-671, 2015 | 159 | 2015 |
| Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease JC Lambert, B Grenier-Boley, D Harold, D Zelenika, V Chouraki, ... Molecular psychiatry 18 (4), 461-470, 2013 | 150 | 2013 |
| Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease V Escott-Price, C Bellenguez, LS Wang, SH Choi, D Harold, L Jones, ... PloS one 9 (6), e94661, 2014 | 149 | 2014 |
| Genome-wide association study of Alzheimer's disease with psychotic symptoms P Hollingworth, R Sweet, R Sims, D Harold, G Russo, R Abraham, ... Molecular psychiatry 17 (12), 1316-1327, 2012 | 144 | 2012 |
| Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene A Ruiz, S Heilmann, T Becker, I Hernández, H Wagner, M Thelen, ... Translational psychiatry 4 (2), e358-e358, 2014 | 132 | 2014 |
| The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease A Gerrish, G Russo, A Richards, V Moskvina, D Ivanov, D Harold, R Sims, ... Journal of Alzheimer's Disease 28 (2), 377-387, 2012 | 93 | 2012 |
| Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE … BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nat Genet 51 (3), 414-430, 2019 | 83 | 2019 |
| No evidence for association between polymorphisms in GRM3and schizophrenia N Norton, HJ Williams, S Dwyer, D Ivanov, AC Preece, A Gerrish, ... BMC psychiatry 5, 1-6, 2005 | 69 | 2005 |
| Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer’s disease RS Thomas, A Henson, A Gerrish, L Jones, J Williams, EJ Kidd BMC neuroscience 17, 1-17, 2016 | 67 | 2016 |
| Shared genetic contribution to ischemic stroke and Alzheimer's disease M Traylor, P Adib‐Samii, D Harold, ... Annals of neurology 79 (5), 739-747, 2016 | 60 | 2016 |
| SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease A Ramirez, WM van der Flier, C Herold, D Ramonet, S Heilmann, ... Human molecular genetics 23 (24), 6644-6658, 2014 | 58 | 2014 |
| Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour A Gerrish, E Stone, S Clokie, JR Ainsworth, H Jenkinson, M McCalla, ... British Journal of Ophthalmology 103 (5), 721-724, 2019 | 57 | 2019 |
